Metabolites in Cancer

Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers around genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

    Related Conference of Metabolites in Cancer

    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 03-04, 2026

    10th Global Meeting on Oncology and Radiology

    Madrid, Spain
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands
    April 27-28, 2027

    37th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 05-06, 2027

    7th World Congress on Breast Cancer

    Berlin, Germany
    May 05-06, 2027

    23rd International Conference on Cancer Research

    Berlin, Germany

    Metabolites in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in